Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Circulating autoantibodies to endothelial progenitor cells: binding characteristics and association with risk factors for atherosclerosis.

George J, Matucci-Cerinic M, Bar I, Shimoni S.

PLoS One. 2014 Jun 19;9(6):e97836. doi: 10.1371/journal.pone.0097836. eCollection 2014.

2.

Decrease in endothelial progenitor cells associated with inflammation, but not with endothelial dysfunction in chronic hemodialysis patients.

Ozkok A, Aktas E, Yilmaz A, Telci A, Oflaz H, Deniz G, Yildiz A.

Clin Nephrol. 2013 Jan;79(1):21-30. doi: 10.5414/CN107318.

PMID:
22909781
3.

Role of circulating endothelial progenitor cells in patients with rheumatoid arthritis with coronary calcification.

Yiu KH, Wang S, Mok MY, Ooi GC, Khong PL, Lau CP, Lai WH, Wong LY, Lam KF, Lau CS, Tse HF.

J Rheumatol. 2010 Mar;37(3):529-35. doi: 10.3899/jrheum.090782. Epub 2010 Jan 15.

PMID:
20080904
4.

Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients.

Oikonomou E, Siasos G, Zaromitidou M, Hatzis G, Mourouzis K, Chrysohoou C, Zisimos K, Mazaris S, Tourikis P, Athanasiou D, Stefanadis C, Papavassiliou AG, Tousoulis D.

Atherosclerosis. 2015 Feb;238(2):159-64. doi: 10.1016/j.atherosclerosis.2014.12.014. Epub 2014 Dec 11.

PMID:
25525743
5.

Circulating endothelial progenitor cells in systemic sclerosis: relation to impaired angiogenesis and cardiovascular manifestations.

Nevskaya T, Bykovskaia S, Lyssuk E, Shakhov I, Zaprjagaeva M, Mach E, Ananieva L, Guseva N, Nassonov E.

Clin Exp Rheumatol. 2008 May-Jun;26(3):421-9.

PMID:
18578963
6.

The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?

Narshi CB, Giles IP, Rahman A.

Lupus. 2011 Jan;20(1):5-13. doi: 10.1177/0961203310382429. Epub 2010 Dec 7. Review.

PMID:
21138982
7.

Anti-endothelial cell antibodies in patients with coronary atherosclerosis.

George J, Meroni PL, Gilburd B, Raschi E, Harats D, Shoenfeld Y.

Immunol Lett. 2000 Jul 3;73(1):23-7.

PMID:
10963807
8.

Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure.

Michowitz Y, Goldstein E, Wexler D, Sheps D, Keren G, George J.

Heart. 2007 Sep;93(9):1046-50. Epub 2007 Feb 3.

9.

In vitro up-regulation of E-selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and microscopic polyangiitis.

Muller Kobold AC, van Wijk RT, Franssen CF, Molema G, Kallenberg CG, Tervaert JW.

Clin Exp Rheumatol. 1999 Jul-Aug;17(4):433-40.

PMID:
10464553
10.

Anti-mesangial and anti-endothelial cell antibodies in IgA mesangial nephropathy.

Fornasieri A, Pinerolo C, Bernasconi P, Li M, Armelloni S, Gibelli A, D'Amico G.

Clin Nephrol. 1995 Aug;44(2):71-9.

PMID:
8529312
11.

Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis--results from a large population-based study.

Xiao Q, Kiechl S, Patel S, Oberhollenzer F, Weger S, Mayr A, Metzler B, Reindl M, Hu Y, Willeit J, Xu Q.

PLoS One. 2007 Oct 10;2(10):e975.

12.

Circulating endothelial progenitor cells and age-related white matter changes.

Jickling G, Salam A, Mohammad A, Hussain MS, Scozzafava J, Nasser AM, Jeerakathil T, Shuaib A, Camicioli R.

Stroke. 2009 Oct;40(10):3191-6. doi: 10.1161/STROKEAHA.109.554527. Epub 2009 Jul 23.

13.

Circulating endothelial progenitor cells correlate with erectile function in patients with coronary heart disease.

Baumhäkel M, Werner N, Böhm M, Nickenig G.

Eur Heart J. 2006 Sep;27(18):2184-8. Epub 2006 Aug 22.

14.

Characterization of circulating endothelial microparticles and endothelial progenitor cells in primary Sjögren's syndrome: new markers of chronic endothelial damage?

Bartoloni E, Alunno A, Bistoni O, Caterbi S, Luccioli F, Santoboni G, Mirabelli G, Cannarile F, Gerli R.

Rheumatology (Oxford). 2015 Mar;54(3):536-44. doi: 10.1093/rheumatology/keu320. Epub 2014 Sep 4.

15.

Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cells.

Praprotnik S, Blank M, Levy Y, Tavor S, Boffa MC, Weksler B, Eldor A, Shoenfeld Y.

Int Immunol. 2001 Feb;13(2):203-10.

16.

Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus.

Lee PY, Li Y, Richards HB, Chan FS, Zhuang H, Narain S, Butfiloski EJ, Sobel ES, Reeves WH, Segal MS.

Arthritis Rheum. 2007 Nov;56(11):3759-69.

17.

[AECA plasmatic levels in patients with severe dyslipidemia and carotid stenosis].

Cesareo R, Iozzino M, Napolitano C, Romitelli F, De Rosa B.

Recenti Prog Med. 2008 May;99(5):252-4. Italian.

PMID:
18581967
18.

Agonistic anti-ICAM-1 antibodies in scleroderma: activation of endothelial pro-inflammatory cascades.

Wolf SI, Howat S, Abraham DJ, Pearson JD, Lawson C.

Vascul Pharmacol. 2013 Jul-Aug;59(1-2):19-26. doi: 10.1016/j.vph.2013.05.002. Epub 2013 May 16.

19.

High prevalence of anti-apolipoprotein/A-1 autoantibodies in maintenance hemodialysis and association with dialysis vintage.

Pruijm M, Schmidtko J, Aho A, Pagano S, Roux-Lombard P, Teta D, Burnier M, Vuilleumier N.

Ther Apher Dial. 2012 Dec;16(6):588-94. doi: 10.1111/j.1744-9987.2012.01102.x. Epub 2012 Sep 12.

PMID:
23190520
20.

Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-inflammatory phenotype in vitro.

Del Papa N, Raschi E, Moroni G, Panzeri P, Borghi MO, Ponticelli C, Tincani A, Balestrieri G, Meroni PL.

Lupus. 1999;8(6):423-9.

PMID:
10483009
Items per page

Supplemental Content

Write to the Help Desk